
Thirty zzso patients with progressive and measurable solid tumors zzso zzso or zzso diseases zzso zzso were given zzso at the dose of 5 zzso in 250 zzso normal saline over 30 minutes infusion for 3 consecutive days every 3 zzso A total of 104 cycles were zzso median 3 for each zzso zzso cycles were delayed for a median of 9 days (from 2 to 59 zzso because of zzso grade I to III zzso zzso no infection or bleeding was zzso Grade I to II zzso was recorded in 16 zzso zzso cardiac toxicity was observed in one patient previously treated with zzso zzso at the studied dose schedule in heavily zzso subjects was well tolerated every 3 to 4 zzso In zzso patients zzso for response, one patient had a zzso another had zzso reduction (both patients previously zzso and zzso patients obtained disease zzso This effectiveness, 1 zzso 1 zzso 11 disease stability, is not negligible when it is considered that zzso was the seventh median line of therapy and the fifth median zzso zzso 

